A Step Closer to a ‘Simple, Cheap Blood Test’ to Diagnose Alzheimer’s?

New research from the University of Central Lancashire may one day lead to a simple method to diagnose Alzheimer’s. But first, far more testing is needed.

7:00 AM

Author | Henry Paulson, M.D., Ph.D.

For years, clinicians and scientists have been searching for a reliable, accessible and inexpensive test that can help diagnose Alzheimer's disease and other forms of dementia.

MORE FROM THE LAB: Subscribe to our weekly newsletter

This would help pair proper treatment to each disease and identify patients in the earliest phases who then might qualify for clinical trials to find disease-slowing therapy.

Existing options, however, fall short.

A cerebrospinal fluid analysis is helpful in diagnosing Alzheimer's disease, but it requires an invasive procedure — a spinal tap — which not everyone is willing to do. Positron emission tomography (PET) brain imaging of beta-amyloid or tau also can lead to the right diagnosis, but it is expensive and not covered by insurance.

In other words, a simple, cheap blood test to detect Alzheimer's, or distinguish Alzheimer's from other forms of dementia, could be a game changer.

A recent study in the Proceedings of the National Academy of Sciences takes us a step in that direction.

The authors, from the University of Central Lancashire in the United Kingdom, used a special form of spectroscopy known as attenuated total reflection (ATR) FTIR spectroscopy to examine blood samples from more than 500 people, most of whom had one of many neurodegenerative diseases, including Alzheimer's.

FTIR spectroscopy provides a "snapshot" of the landscape of proteins, lipids and nucleic acids in the blood plasma. Subtle differences in this landscape can be teased out using special techniques and statistical methods to identify key features that might distinguish someone with Alzheimer's, for example, from someone without dementia.

SEE ALSO: 4 Takeaways from 'The Lancet' Report on Alzheimer's Disease Burden

The authors did precisely that, coming up with a test that was 70 percent sensitive and specific in detecting Alzheimer's disease from healthy controls. The test was improved by incorporating results of the major genetic risk factor for Alzheimer's, the Apolipoprotein E (ApoE) genotype.

Diagnosing Alzheimer's vs. Lewy body dementia

Perhaps the most striking finding in the study was the ability of the spectroscopy test to distinguish Alzheimer's from Lewy body dementia. LBD, the second most common primary dementia, is often confused with Alzheimer's, leading to misdiagnosis and inappropriate medical treatment.

The test was even better in distinguishing Alzheimer's from LBD, achieving 90 percent sensitivity and specificity.

Is this test ready for the clinic? Not yet.

It will be important to put this diagnostic test through its paces, testing it in an independent population that includes a much greater number of patients with the earliest signs of Alzheimer's disease process and ideally includes parallel cerebrospinal fluid or PET imaging biomarker data. In doing so, we can determine precisely how good a relatively noninvasive and inexpensive test like this can be.

The search continues for that cheap, accessible and reliable test, but maybe we are one step closer.

More Articles About: Body Work Alzheimer's Disease Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories Patient lies in hospital bed after surgery with bandage on head, displays toys later after recovery
Health Lab
Lifechanging results for young woman after orange-sized brain tumor removed
Young woman thrives after surgery to remove a pilocytic astrocytoma tumor in her brain.
Three year old patient poses by Wonder Woman statue, wears costume
Health Lab
Three-year-old Wonder Woman making strides after customized spinal procedure
Three year old Wonder Woman fan thrives after customized minimally invasive selective dorsal rhizotomy to help symptoms of cerebral palsy and spastic diplegia
Illustration of neuron cell
Health Lab
Two genes linked to autism implicated in brain cell connectivity
A new study links two autism-associated genes together for the first time, potentially revealing a mechanism behind brain changes seen in people with autism.
brain image
Health Lab
Death rate higher than expected for patients with functional, nonepileptic seizures
The death rate for patients with functional, nonepileptic seizures is higher than expected, with a rate comparable to epilepsy and severe mental illness, a Michigan Medicine-led study finds.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Identifying Dementia from EHR Data
In 2009, the Health Information Technology for Economic and Clinical Health Act, wow, that's a mouthful, more commonly known as the HITECH Act, spent billions to promote the uptake of electronic health records by US hospitals. Fast forward more than a decade later, and now approximately four out of five healthcare institutions have electronic health record systems in place that integrate clinical notes, test results, medications, diagnostic images, et cetera. The adoption of EHR systems into healthcare introduces new and exciting opportunities to extract information that can be used to augment other types of data for research. As you might imagine though, it can be tricky to pull out meaningful information from the text of clinical notes. In this episode, we'll speak with a University of Michigan researcher, Dr. Vinod Vydiswaran, who's been developing methods to identify dementia from EHR data.
Brain cancer patient gives thumbs up; smiling doctors pose at left
Health Lab
Father’s journey with glioblastoma inspires son to become neurosurgeon
Physician in training inspired to specialize in neurosurgery after losing his father to brain cancer, continues to raise funds for glioblastoma research